Blocking agents help overcome immune rejection of stem cells in mice

03/3/2011 | Google

Scientists at Stanford University reported in the journal Cell Stem Cell that they were able to overcome immune system rejection of transplanted embryonic stem cells in mice after administering a short-term treatment with three co-stimulatory receptor blocking agents, drugs that "teach" T cells to accept transplanted cells. The finding might allow patients to receive donor cells without requiring them to use immunosuppressive drugs and might help prevent transplanted early-stage cells from turning into tumors.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA